Form 4 for EDSA Edesa Biotech, Inc.
Accepted 2025-02-14 00:00:00 ET · period of report 2025-02-12 · accession 0001171843-25-000867 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-14 | 2025-02-12 | EDSA | Marshall Patrick | Dir | A - Grant | $1.92 | +41.7K | 41.7K | New | +$80.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-02-12 | A | A | 41,666 | $1.92 | 41,666 | D | — | — | (F1) On February 12, 2025, the Reporting Person purchased in a private placement, 41,666 common shares, without par value, of the Issuer, for a purchase price of $1.92 per share. |